Communiqués

16/10/23 TeamBest Global Companies - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies AQ
21/07/23 ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR
17/07/23 ViewRay® Files Voluntary Chapter 11 Petitions PR
30/06/23 ViewRay : Failure to Satisfy Listing Rule - Form 8-K PU
13/06/23 VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System PR
12/05/23 ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting PR
10/05/23 ViewRay: Q1 Earnings Snapshot AQ
10/05/23 VIEWRAY, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
10/05/23 ViewRay Announces First Quarter 2023 Results PR
09/05/23 ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023 PR
13/04/23 VIEWRAY, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
13/04/23 ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value PR
12/04/23 ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023 PR
14/03/23 VIEWRAY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
07/03/23 Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients PR
02/03/23 Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy PR
28/02/23 VIEWRAY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ
27/02/23 ViewRay: Q4 Earnings Snapshot AQ
27/02/23 VIEWRAY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
27/02/23 ViewRay : Appendix PU
27/02/23 ViewRay Announces Fourth Quarter and Full Year 2022 Results PR
31/01/23 ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023 PR
20/01/23 VIEWRAY, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) AQ
20/01/23 ViewRay Enters into Cooperation Agreement with Hudson Executive Capital PR
09/01/23 VIEWRAY, INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Aucun résultat pour cette recherche